Walleye Capital’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7 Buy
+2
New +$8 ﹤0.01% 5910
2025
Q2
– Sell
-20,993
Closed -$127K – 4857
2025
Q1
$127K Buy
+20,993
New +$106K ﹤0.01% 3521
2024
Q4
– Sell
-13,597
Closed -$79.5K – 5284
2024
Q3
$79.5K Buy
+13,597
New +$67K ﹤0.01% 4486
2023
Q4
– Sell
-81,957
Closed -$447K – 5308
2023
Q3
$447K Sell
81,957
-141,258
-63% -$1.13M ﹤0.01% 2902
2023
Q2
$2.07M Sell
223,215
-315,652
-59% -$2.67M 0.01% 1299
2023
Q1
$4.43M Buy
+538,867
New +$5.95M 0.07% 362
2022
Q2
– Sell
-113,633
Closed -$2.4M – 2578
2022
Q1
$2.4M Buy
113,633
+81,267
+251% +$1.75M 0.06% 321
2021
Q4
$765K Buy
32,366
+2,000
+7% +$42.8K 0.02% 737
2021
Q3
$609K Sell
30,366
-59,488
-66% -$1.22M 0.02% 696
2021
Q2
$1.81M Buy
+89,854
New +$1.92M 0.06% 268

Other funds holding MPT

Walleye Capital's MPT Position: Q3 2026 in Review

Walleye Capital opened a new position in Medical Properties Trust (MPT) in Q3 2026: 2 shares worth $7. The stake represents ﹤0.01% of the portfolio and ranks #5910 among its holdings. This is a return to the name: Walleye Capital previously reported a position in MPT as recently as Q1 2025.

Walleye Capital first reported a position in MPT in Q2 2021 and has held it in 10 quarters since. The position peaked at $4.43M in Q1 2023. 459 funds tracked by Wall St. Rank hold MPT as of Q3 2026.

  • Walleye Capital held 2 shares of Medical Properties Trust worth $7 as of Q3 2026.
  • Medical Properties Trust was a new Walleye Capital position in Q3 2026.
  • Medical Properties Trust made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #5910 holding.
  • Walleye Capital first reported a position in Medical Properties Trust in Q2 2021 and has held it in 10 quarters since.
  • Walleye Capital's Medical Properties Trust position peaked at $4.43M in Q1 2023.
  • 459 funds tracked by Wall St. Rank held Medical Properties Trust as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.